SCHEMBL7071352

SCHEMBL7071352

O=C(NC1CC2CCC1N2)c1ccc(Br)s1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.55
HPGD P15428 2/20 0.55
TDP1 Q9NUW8 2/20 0.48
POLB P06746 2/20 0.45
NPC1 O15118 5/20 0.42
RAB9A P51151 5/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
NPSR1 Q6W5P4 2/20 0.42
RXFP1 Q9HBX9 2/20 0.42
GAA P10253 1/20 0.41
KDM4E B2RXH2 1/20 0.40
ESR1 P03372 1/20 0.40
NFKB1 P19838 1/20 0.40
CASP3 P42574 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7225002 1.00 ALDH1A1 (0.55) ALDH1A1HPGDTDP1POLBNPC1
Hydrochloric Acid SCHEMBL7232683 0.99 ALDH1A1 (0.53) ALDH1A1HPGDTDP1POLBNPC1
Hydrochloric Acid SCHEMBL7073092 0.99 ALDH1A1 (0.53) ALDH1A1HPGDTDP1POLBNPC1
Hydrochloric Acid SCHEMBL7077941 0.99 ALDH1A1 (0.53) ALDH1A1HPGDTDP1POLBNPC1
SCHEMBL7223510 0.84 NPC1 (0.52) ALDH1A1TDP1POLBNPC1RAB9A
SCHEMBL7223199 0.84 HDAC6 (0.40) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL7224677 0.84 MEN1 (0.43) RAB9ASMN1; SMN2MEN1KMT2AGAA
Hydrochloric Acid SCHEMBL7231904 0.83 NPC1 (0.51) ALDH1A1TDP1POLBNPC1RAB9A
Hydrochloric Acid SCHEMBL7233032 0.83 F10 (0.43) RAB9ASMN1; SMN2MEN1KMT2AGAA
SCHEMBL7226147 0.81 SLC6A3 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562816-B2 Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects PHARMACIA & UPJOHN COMPANY 2003-05-13 US claimed
US-20030069290-A1 SUBSTITUTED-HETEROARYL-7-AZA[2.2.1] BYCYCLOHEPTANES FOR THE TREATMENT OF DESEASE PHARMACIA & UPJOHN COMPANY 2003-04-10 US claimed
US-6562816-B2 Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects PHARMACIA & UPJOHN COMPANY 2003-05-13 US disclosed
US-20030069290-A1 SUBSTITUTED-HETEROARYL-7-AZA[2.2.1] BYCYCLOHEPTANES FOR THE TREATMENT OF DESEASE PHARMACIA & UPJOHN COMPANY 2003-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030069290-A1 SUBSTITUTED-HETEROARYL-7-AZA[2.2.1] BYCYCLOHEPTANES FOR THE TREATMENT OF DESEASE SULT1E1, UGT1A7, UGT1A1 ALDH1A1 1238/4885HPGD 1427/4885TDP1 1132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.